WCM
BSX icon

Weld Capital Management’s Boston Scientific BSX Stock Holding History

Weld Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-12,191
Closed -$471K – 239
2021
Q1 		$471K Buy
+12,191
New +$461K 0.2% 190
2019
Q4 		– Sell
-15,373
Closed -$626K – 622
2019
Q3 		$626K Buy
15,373
+3,410
+29% +$144K 0.11% 306
2019
Q2 		$514K Buy
+11,963
New +$460K 0.09% 376

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Weld Capital Management's BSX Position: Q2 2021 in Review

Weld Capital Management sold out of Boston Scientific (BSX) in Q2 2021, closing a stake of 12,191 shares — an estimated $471K sold.

Weld Capital Management first reported a position in BSX in Q2 2019 and held it in 3 quarters. The position peaked at $626K in Q3 2019. 870 funds tracked by Wall St. Rank hold BSX as of Q2 2021.

  • Weld Capital Management reported no remaining Boston Scientific position as of Q2 2021 after selling out during the quarter.
  • Weld Capital Management sold 12,191 Boston Scientific shares in Q2 2021, an estimated $471K.
  • Weld Capital Management first reported a position in Boston Scientific in Q2 2019 and held it in 3 quarters.
  • Weld Capital Management's Boston Scientific position peaked at $626K in Q3 2019.
  • 870 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2021.

Based on Weld Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.